ISPE and its members have been leading the way on was on how Industry 4.0 will inform the development of Pharma 4.0 and its implications for pharmaceuticals and the life sciences. Implementing new industry 4.0-based manufacturing concepts in Pharma 4.0 requires alignment of expectations, interpretation, and definitions.
While Pharma 4.0 has been called a new industrial revolution, its implementation will more likely resemble an evolution in which digitization and automation meet a very complex product portfolios with long life-cycles. It is therefore important to achieve a common understanding of readiness and maturity, starting with enablers and components defined in ICH Q10: Pharmaceutical Quality System. It is also important to develop business cases to be certain the right products are identified, such as full automation.
Digitization, an important component of Pharma 4.0, will connect everything, creating new levels of transparency and speed. This will enable faster decision-making, and provide in-line and in-time control over business, operations, and quality. It will also require higher levels of security, since connected systems heighten vulnerability.
ISPE’s Pharma 4.0 Special Interest Group (SIG) has developed an operating model for moving from Industry 4.0 to Pharma 4.0 which is shown in the image below.
The Pharma 4.0 SIG is working on pharma-specific maturity models, as well as those already defined in other industries, via its five subgroups:
In addition to supporting a very active special interest group, ISPE has spearheaded the first conference devoted to Pharma 4.0, 2017 ISPE Europe Pharma 4.0 Conference, which took place 23-24 November in Verona, Italy. At this event over 230 participants from 19 countries gathered to discuss topics that included end-to-end integration, data integrity and analytics, automation, and the workforce of the future.
To help participants understand the concepts put forward by the SIG, a group of Young Professionals developed and presented a role-playing workshop. Using a series of virtual businesses, the audience had to determine each one’s Pharma 4.0 readiness factor and identify what was needed from each segment of the business to achieve it. Attendees agreed that two factors were required for successful implementation: First, management must consider Pharma 4.0 a strategic value and create a corporate culture to nurture its growth. Second, management must decide what “Workforce 4.0” might look like.
The 2018 ISPE Europe Annual Conference in Rome, Italy, attracted over 600 attendees, with Pharma 4.0 one of the hot topics discussed during the conference. Read more about the event on our iSPEAK blog.
You can also read a more in-depth article in our July/August issue of Pharmaceutical Engineering magazine.
ISPE is leading the way with the migration to Pharma 4.0 and will continue to do so through its conferences and publications.